Aethlon Medical Inc (NASDAQ:AEMD) has a beta value of 1.91 and has seen 4.89 million shares traded in the last trading session. The company, currently valued at $12.65M, closed the last trade at $0.91 per share which meant it gained $0.11 on the day or 13.22% during that session. The AEMD stock price is -145.05% off its 52-week high price of $2.23 and 73.63% above the 52-week low of $0.24. If we look at the company’s 10-day average daily trading volume, we find that it stood at 12.22 million shares traded. The 3-month trading volume is 2.94 million shares.
The consensus among analysts is that Aethlon Medical Inc (AEMD) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Aethlon Medical Inc (NASDAQ:AEMD) trade information
Sporting 13.22% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the AEMD stock price touched $0.91 or saw a rise of 13.74%. Year-to-date, Aethlon Medical Inc shares have moved 5.33%, while the 5-day performance has seen it change 49.57%. Over the past 30 days, the shares of Aethlon Medical Inc (NASDAQ:AEMD) have changed 136.87%. Short interest in the company has seen 0.29 million shares shorted with days to cover at 0.98.
Aethlon Medical Inc (AEMD) estimates and forecasts
Figures show that Aethlon Medical Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 117.90% over the past 6 months, with this year growth rate of 79.22%, compared to -4.50% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 37.58% over the past 5 years.
AEMD Dividends
Aethlon Medical Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aethlon Medical Inc (NASDAQ:AEMD)’s Major holders
Insiders own 0.54% of the company shares, while shares held by institutions stand at 3.09% with a share float percentage of 3.11%. Investors are also buoyed by the number of investors in a company, with Aethlon Medical Inc having a total of 18.0 institutions that hold shares in the company.
